Publication date: Jul 09, 2019
OBJECTIVE. We describe the range of organ systems involved and the spectrum of imaging findings seen in WaldenstrcF6m macroglobulinemia (WM). CONCLUSION. Although imaging is not mandatory in the initial workup of a patient with WM, a multimodality imaging approach can lead toward the diagnosis of a lymphoproliferative disorder, establish the tumor burden, identify sites of involvement, and thus explain the clinical presentation, help in determining prognosis and monitoring response to therapy, and help identify treatment-induced toxicity.
Thomas, R., Braschi-Amirfarzan, M., Laferriere, S.L., and Jagannathan, J.P. Imaging of Waldenstr”om Macroglobulinemia: A Comprehensive Review for the Radiologist in the Era of Personalized Medicine. 04977. 2019 AJR Am J Roentgenol.
- Pathology Machine Learning in Practice: Clinical trial and translational research applications
- Robot vs Doctor | Is Artificial Intelligence the Future of Medicine?
- Immune precision medicine for cancer: a novel insight based on the efficiency of immune effector cells.
- Human Plasma Metabolomics in Age-Related Macular Degeneration: Meta-Analysis of Two Cohorts.
- AI in the Clinic Panel – 2019 Stanford Medicine Big Data | Precision Health